🇪🇺 PENBRAYA in European Union

EMA authorised PENBRAYA on 14 November 2024

Marketing authorisation

EMA — authorised 14 November 2024

  • Application: EMEA/H/C/006165
  • Marketing authorisation holder: Pfizer Europe MA EEIG
  • Local brand name: Penbraya
  • Indication: Penbraya is indicated for active immunisation of individuals 10 years of age and older to prevent invasive disease caused by Neisseria meningitidis groups A, B, C, W, and Y. The use of this vaccine should be in accordance with official recommendations.
  • Status: withdrawn

The European Medicines Agency (EMA) has granted marketing authorisation for PENBRAYA, a vaccine, on 14 November 2024. PENBRAYA is indicated for active immunisation of individuals 10 years of age and older to prevent invasive disease caused by Neisseria meningitidis groups A, B, C, W, and Y. The use of this vaccine should be in accordance with official recommendations.

Read official source →

Other Infectious Disease approved in European Union

Frequently asked questions

Is PENBRAYA approved in European Union?

Yes. EMA authorised it on 14 November 2024.

Who is the marketing authorisation holder for PENBRAYA in European Union?

Pfizer Europe MA EEIG holds the EU marketing authorisation.